How Technology Is Making the Golden Quarter a Success
Listen now
Description
Aaron Goldman, CMO, Mediaocean joins me in a discussion about “The Golden Crunch Point”. As we are all aware, we are entering that time in the marketing calendar where for many brands, the majority of their revenue and sales are made – the Golden Quarter. These three months have always been huge but this year it has been amplified with the continued unpredictable headwinds of cost of living, changing consumer confidence and a potential recession. The crunch point for brands is that, while retail sales are expected to be lower this year - while consumers are more cautious of what they spend their money on - they still to need to make revenue. Aaron discusses “the four must haves” brands and retailers need for their Golden Quarter campaigns this year to entice new and existing customers outside discount and deals. With $200 billion in annualized ad spend running through its software, I also learn more about how Mediaocean provides foundational solutions to connect brands, agencies, media, technology, and data. About Mediaocean Mediaocean is the mission-critical platform for omnichannel advertising. With more than $200 billion in annualized media spend managed through its software, Mediaocean connects brands, agencies, media, technology, and data. Using AI and machine learning technology to control marketing investments and optimize business outcomes, Mediaocean powers campaigns from planning, buying, ad serving, and creative personalization to analysis, optimization, invoices, and payments. Mediaocean employs 1,700 staff across 30 global offices and supports over 100,000 people using its products
More Episodes
Today's guest is Sameer Kazi, President of ActiveCampaign, who is responsible for guiding the core operations and helping prepare the company for its next growth phase. We discuss how ActiveCampaign is helping businesses grow by scaling their customer experiences and data points from the Customer...
Published 02/05/23
Contract Research Organisations (CROs) are a vital cog in the pharmaceutical industry – they provide essential support services to help companies conduct clinical research more efficiently and effectively, saving money and time. Whilst CROs traditionally largely involve data management, new...
Published 02/04/23
Published 02/04/23